ropack articles
-
5 Must-Haves In A Contract Packaging Partner
A contract packaging partner should function as an extension of the pharma’s organization, so careful consideration should be devoted to initiating this relationship.
-
U.S. Clinical Labels 101: Steps To Ensure Accuracy
Determining a drug candidate’s probability of commercial success is a significant phase in the drug development process. There is no room for error.
-
4 Reasons For The Rise In Blister Packaging
Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.
-
Four Reasons For The Rise In Blister Packaging
Explore the factors that are driving blister packaging to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.
-
How To Survive An FDA Audit
Understanding the FDA audit process, preparing for it and being aware of regulations will help to restore a sense of control and help to ensure the best outcome.
-
Benefits Of Blister Packaging For Emerging Markets
Emerging countries offer a nearly untapped opportunity. Despite the opportunities, these markets also hold unique challenges. Blister packaging effectively addresses these challenges.
-
Drug Safety And Product Protection Driving Blister Packaging Growth
Learn why the trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market.
-
Embrace Quality Risk Management To Build A Strong Quality Culture
Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.
-
A Cost-Effective Approach To Cleaning Validation And Verification
From fully developed large-scale manufacturing and packaging to a single development batch, a contract services organization must be prepared to handle multiple compounds in the same facility.
-
A Bridge Over Troubled Water: The Journey To Serialization Compliance
This regulation from the FDA outlined serialization and traceability requirements spread over the course of 10 years with preparation for each phase accumulating into a potentially high overall price tag.